Longevity OS
Your center optimizes the body. We add the brain.
A complete brain wellness pathway for longevity clinics, centers, and luxury wellness destinations.
We make the brain measurable.
Brain measurement intelligence for longevity care and CNS development—turning brain-wave data into clear client insights and AI-based biomarkers.
Book a live demo500K+
Brain scans
200M
Medical notes
Presented at
TEDx
World Economic Forum
Nasdaq
Programs & affiliations
Harvard Innovation Labs
J&J Innovation JLABS
Merck Digital Sciences
NVIDIA Inception
Pharma & Biotech R&D
Make the next decision on your CNS asset with greater confidence.
Treatment-response prediction, monitoring markers, PK/PD brain effects, and comparison with 500K+ brain scans.
One platform.
Two pathways.
The same brain measurement intelligence powers personalized care and biopharma breakthroughs.
The infrastructure behind both pathways
01
Brain Measurement Kit
Guided brain-wave measurement for longevity care, research, and distributed trials.
Learn more02
Datahub
Cleans and structures brain data into research-grade, trial-ready cohorts.
Learn more03
Foundational Brain Model
Produces task-specific, AI-based biomarkers for defined development questions.
Learn moreProof in practice
Used in care. Validated in trials.
One measurement platform supports two different outcomes: a clearer client experience for longevity teams and better-informed development decisions for CNS programs.
Longevity OS
A client experience people can see, understand, and return to.
An approximately 10-minute brain-wave assessment becomes a co-branded Brain Wellness Report and a clear before-and-after conversation.
Book a Longevity OS demo“Brainify.AI Longevity OS lets us give every client a clear before-and-after view of their cognitive wellness alongside our psychology and performance programs. It’s exactly the kind of differentiated, science-led experience we want to be known for in Saudi Arabia.”
Pharma & Biotech
Clinical evidence for the next decision on a CNS asset.
Population-scale data, foundational brain models, and simplified EEG / ERP collection support AI-based biomarker decisions from preclinical work through Phase III.
+11.1%
Observed response-rate difference
CAN-BIND-1 retrospective analysis
p = 0.01
Placebo-risk stratification
EMBARC analysis
86% / 79%
Sensitivity / specificity
Alzheimer's analysis
Company
Science, product, and operating depth behind the platform.
A multidisciplinary team of neuroscientists, AI researchers, engineers, and operators building one measurement platform for care and clinical development.
5
Patents secured
10+
Industry partners
2
Global offices
New York · Dubai
FAQ
Questions, answered clearly.
The practical questions teams ask before deciding whether a Brainify.AI meeting is relevant.
See what Brainify.AI can add to your program.
Choose the conversation that fits your organization. We’ll show the relevant product, workflow, evidence, and next step.